Study of multi gene panel shows heredity risk of breast and ovarian cancer

[News]

Invitae Corporation, a genetic information company, and its collaborators have announced the publication of new data describing the clinical actionability of multi-gene testing for hereditary...

More... (http://www.medicalnewstoday.com/releases/298224.php)